actinomycin X2

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Prostatic Neoplasms (Prostate Cancer) 03/01/2016 - "The present study aimed to determine whether actinomycin X2 (AX2) intercepted the mTOR/PTEN/PI3K/Akt signaling pathway to inhibit human prostate cancer cells (PC-3) in vitro. " 03/01/2016 - "Apoptosis of human prostate cancer cells induced by marine actinomycin X2 through the mTOR pathway compounded by MiRNA144."
2.	Tuberculosis (Tuberculoses) 08/01/2012 - "A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity."
3.	Leukemia 08/01/2006 - "Actinomycin X2 has higher cytotoxicity toward cultured human leukemia (HL-60) cells than does actinomycin D, and it induces cell death via apoptosis. "

1.	Dactinomycin (Actinomycin)